Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-25T08:21:57.107Z Has data issue: false hasContentIssue false
  • English
  • Français

Clostridium difficile-associated diarrhoea: epidemiological data from Western Australia

Published online by Cambridge University Press:  15 May 2009

T. V. Riley ,
G. L. O'Neill ,
R. A. Bowman  and
C. L. Golledge
T. V. Riley
Affiliation:
Health Services Statistics and Epidemiology Branch, Health Department of Western Australia, 189 Royal Street, East Perth 6004, Western, Australia National Centre for Epidemiology and Population Health, The Australian National University, GPO Box 4, Canberra 2604, Australian Capital Territory Department of Microbiology, The University of Western Australia, Queen Elizabeth II Medical Centre, Nedlands 6009, Western, Australia Department of Clinical Microbiology, Sir Charles Gairdner Hospital, Queen Elizabeth II Medical Centre, Nedlands 6009, Western, Australia
G. L. O'Neill
Affiliation:
Department of Microbiology, The University of Western Australia, Queen Elizabeth II Medical Centre, Nedlands 6009, Western, Australia
R. A. Bowman
Affiliation:
Department of Microbiology, The University of Western Australia, Queen Elizabeth II Medical Centre, Nedlands 6009, Western, Australia Department of Clinical Microbiology, Sir Charles Gairdner Hospital, Queen Elizabeth II Medical Centre, Nedlands 6009, Western, Australia
C. L. Golledge
Affiliation:
Department of Microbiology, The University of Western Australia, Queen Elizabeth II Medical Centre, Nedlands 6009, Western, Australia Department of Clinical Microbiology, Sir Charles Gairdner Hospital, Queen Elizabeth II Medical Centre, Nedlands 6009, Western, Australia
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The incidence of Clostridium difficile-associated diarrhoea (CDAD) was investigated retrospectively at a 690-bed teaching hospital for the period 1983–92. Our aims were to determine: (i) the distribution by age and sex of patients with CDAD, (ii) the possibility of a seasonal trend and, (iii) the influence of infection control procedures, contamination of the hospital environment and the use of third-generation cephalosporins. The laboratory diagnosis of CDAD was based on demonstration of the organism by stool culture and/or detection of specific cytotoxin in stool filtrates. C. difficile was detected in 917 patients who were being investigated for diarrhoeal illness. Yearly isolations varied from a low of 49 in 1983 to a high of 120 in 1990 (Chi square for linear trend 128·8; P < 0·005). Most patients were elderly, with 63% aged 60 years or more; the majority (59%) were female. The relationship between culture of C. difficile and detection of cytotoxin in faecal extracts was also examined. Sixty percent of a sample of 132 isolates from patients in whom faecal cytotoxin was not detected produced cytotoxin in vitro, suggesting that culture is a more sensitive indicator of infection with C. difficile than cytotoxin detection. When the total number of faecal specimens received in the laboratory was used as a denominator there was an increase in the number of incident cases of CDAD between 1983 and 1990, apart from 1986. When occupied bed days was used as the denominator a similar trend was observed with a peak in 1990. These increases correlated with an increase in the use of third-generation cephalosporins at SCGH between 1983 and 1989 (Pearson's correlation coefficient, 0·90). The introduction of Body Substance Isolation in 1989, in conjunction with other infection control procedures, appears to have halted the rise, despite a continuing use of broad-spectrum cephalosporins. In order to reduce the number of cases of CDAD, either a reduction in levels of environmental contamination or a reduction in the use of third-generation cephalosporins is required. If this can be achieved the economic consequences, in terms of an opportunity cost, will be considerable.

Type
Research Article
Information
Epidemiology & Infection , Volume 113 , Issue 1 , August 1994 , pp. 13 - 20
Copyright
Copyright © Cambridge University Press 1994

References

REFERENCES

1.Bartlett, JG, Chang, TW, Gurwith, M, Gorbach, SL, Onderdonk, AB. Antibiotic-associated pseudomembranous colitis due to toxin producing clostridia. N Engl J Med 1978; 298: 531–4.Google Scholar
2.McFarland, LV, Mulligan, ME, Kwok, RYY, Stamm, WE. Nosocomial acquisition of Clostrium difficile infection. New Engl J Med 1989; 320: 204–10.Google Scholar
3.Wilkins, E. Tres difficile. J Infect 1993; 26: 1–7.CrossRefGoogle ScholarPubMed
4.Riley, TV, Bowman, RA, Carroll, SM. Diarrhoea associated with Clostridium difficile in a hospital population. Med J Aust 1983; 1: 166–9.Google Scholar
5.Zimmerman, RH. Risk factors for Clostridium difficile cytotoxin-positive diarrhoea after control for horizontal transmission. Infect Control Hosp Epidemiol 1991; 12: 96–100.Google Scholar
6.Golledge, CL, McKenzie, T, Riley, TV. Extended spectrum cephalosporins and Clostridium difficile. J Antimicrob Chemother 1989; 23: 929–31.Google Scholar
7.Kim, KH, Fekety, R, Batts, DH et al. , Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis 1981; 143: 42–50.Google Scholar
8.Bowman, RA, Riley, TV. The laboratory diagnosis of Clostridium difficile-Associated diarrhoea. European J Clin Microbiol Infect Dis 1988; 7: 476–84.Google Scholar
9.Lynch, P, Jackson, MM, Cummings, MJ, Stamm, WE. Rethinking the role of isolation practices in the prevention of nosocomial infections. Ann Intern Med 1987; 107: 243–6.Google Scholar
10.Lyerly, DM, Krivan, HC, Wilkins, TD. Clostridium difficile: its disease and toxins. Clin Microbiol Rev 1988; 1: 1–18.Google Scholar
11.Bowman, RA, Rilev, TV. Routine culturing for Clostridium difficile? Pathology 1984; 16: 240–2.Google Scholar
12.Carroll, SM, Bowman, RA, Riley, TV. A selective broth for Clostridium difficile. Pathology 1983; 15: 165–7.Google Scholar
13.Bowman, RA, Arrow, SA, Riley, TV. Latex particle agglutination for detection and identifying Clostridium difficile. J Clin Pathol 1986; 39: 212–14.CrossRefGoogle ScholarPubMed
14.Brown, E, Talbot, GA, Axelrod, P, Provencher, M, Hoegg, C. Risk factors for Clostridium difficile toxin-associated diarrhea. Infect Control Hosp Epidemiol 1990; 11: 283–90.Google Scholar
15.Viscidi, R, Laughon, BE, Yolken, R et al. , Serum antibody response to toxins A and B of Clostridium difficile. J Infect Dis 1983; 148: 93–100.CrossRefGoogle Scholar
16.McFarland, LV, Stamm, WE. Review of Clostridium difficile-associated diseases. Am J Infect Control 1986; 14: 99–109.Google Scholar
17.Smith, G, Dealler, S, Anson, J, Tompkins, D. Diagnosis of pseudomembranous colitis. Lancet 1992; 340: 735.CrossRefGoogle ScholarPubMed
18.O'Neill, GL, Beaman, MH, Riley, TV. Relapse versus reinfection with Clostridium difficile. Epidemiol Infect 1991; 107: 627–35.Google Scholar
19.Johnson, S, Gerding, DN, Olson, MM et al. , Prospective controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med 1990; 88: 137–40.CrossRefGoogle ScholarPubMed
20.Eriksson, S, Aronsson, B. Medical implications of nosocomial infection with Clostridium difficile. Scand J Infect Dis 1989; 21: 733–4.CrossRefGoogle ScholarPubMed